Menu
Back to User profile » Prof. Dr. Fabiola Atzeni
Papers published by Prof. Dr. Fabiola Atzeni:
Anti-IL-17 Agents in the Treatment of Axial Spondyloarthritis
Atzeni F, Carriero A, Boccassini L, D'Angelo S
ImmunoTargets and Therapy 2021, 10:141-153
Published Date: 3 May 2021
Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study
Cimmino MA, Parodi M, Barbieri F, Bombardieri S, Zampogna G, Iagnocco A, Batticciotto A, Sconfienza LM, Sinigaglia L, De Benedetti F, Atzeni F, Sarzi-Puttini P
Biologics: Targets and Therapy 2020, 14:13-21
Published Date: 11 February 2020
Identifying the symptom and functional domains in patients with fibromyalgia: results of a cross-sectional Internet-based survey in Italy
Salaffi F, Mozzani F, Draghessi A, Atzeni F, Catellani R, Ciapetti A, Di Carlo M, Sarzi-Puttini P
Journal of Pain Research 2016, 9:279-286
Published Date: 13 May 2016
Costs associated with rheumatoid arthritis in Italy: past, present, and future
Benucci M, Rogai V, Atzeni F, Hammen V, Sarzi-Puttini P, Migliore A
ClinicoEconomics and Outcomes Research 2016, 8:33-41
Published Date: 10 February 2016
Antidrug antibodies against TNF-blocking agents: correlations between disease activity, hypersensitivity reactions, and different classes of immunoglobulins
Benucci M, Li Gobbi F , Meacci F, Manfredi M, Infantino M, Severino M, Testi S, Sarzi-Puttini P, Ricci C, Atzeni F
Biologics: Targets and Therapy 2015, 9:7-12
Published Date: 17 February 2015
Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
Benucci M, Saviola G, Manfredi M, Sarzi-Puttini P, Atzeni F
Biologics: Targets and Therapy 2013, 7:69-75
Published Date: 15 March 2013